Spagnoletti, Gionata
 Distribuzione geografica
Continente #
NA - Nord America 1.712
EU - Europa 1.168
AS - Asia 207
AF - Africa 56
OC - Oceania 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.164
Nazione #
US - Stati Uniti d'America 1.699
DE - Germania 326
SE - Svezia 287
IT - Italia 178
CN - Cina 130
UA - Ucraina 107
IE - Irlanda 84
FR - Francia 56
CI - Costa d'Avorio 53
FI - Finlandia 34
GB - Regno Unito 32
IN - India 32
PL - Polonia 24
IR - Iran 18
BE - Belgio 11
ES - Italia 11
AU - Australia 9
CA - Canada 7
SG - Singapore 7
BR - Brasile 6
JP - Giappone 5
MX - Messico 5
NL - Olanda 4
SI - Slovenia 4
CL - Cile 3
EG - Egitto 3
HK - Hong Kong 3
RU - Federazione Russa 3
VN - Vietnam 3
CY - Cipro 2
EU - Europa 2
NO - Norvegia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
DK - Danimarca 1
KR - Corea 1
MD - Moldavia 1
MN - Mongolia 1
PT - Portogallo 1
TR - Turchia 1
Totale 3.164
Città #
Chandler 479
Ashburn 142
Dublin 83
San Mateo 76
New York 73
Ann Arbor 64
Wilmington 61
Abidjan 53
Milan 51
Jacksonville 50
Rome 41
Boston 39
Fairfield 39
Redwood City 37
Princeton 33
Dearborn 26
Nanjing 23
Beijing 22
Warsaw 20
Lawrence 19
Nürnberg 18
Houston 17
Woodbridge 16
Augusta 12
Marseille 12
Andover 11
Brussels 11
Hangzhou 11
Nanchang 10
Zhengzhou 10
Seattle 9
Boardman 8
Hebei 8
Helsinki 8
Shenyang 8
Bremen 7
Redmond 7
Costa Mesa 6
Lancaster 6
Los Angeles 6
Pune 6
São Paulo 6
Washington 6
Cambridge 5
Cattolica 5
Fremont 5
Guangzhou 5
Kish 5
Norwalk 5
Tokyo 5
Mexico 4
Mountain View 4
Romainville 4
San Diego 4
Shanghai 4
Tianjin 4
University Park 4
Bangalore 3
Busto Arsizio 3
Changsha 3
Jiaxing 3
Kraków 3
Leawood 3
London 3
San Francisco 3
Sydney 3
Wuhan 3
Acquaviva delle Fonti 2
Amsterdam 2
Ardabil 2
Bologna 2
Bolzano 2
Changchun 2
Groningen 2
Haikou 2
Hanoi 2
Hong Kong 2
Izola 2
Jinan 2
Kochi 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Las Vegas 2
Ljubljana 2
Lomazzo 2
Martinsicuro 2
Monmouth Junction 2
Montreal 2
Munich 2
Nicosia 2
Oslo 2
Phoenix 2
San Jose 2
Saronno 2
Senigallia 2
Shenzhen 2
Toronto 2
Vancouver 2
Vigevano 2
Totale 1.809
Nome #
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 135
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 113
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 111
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 109
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 106
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 95
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 88
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 87
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 87
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 82
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 82
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 80
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 80
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 80
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 78
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 72
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 70
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 68
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 68
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 66
Evolution of causes of mortality in renal transplantation in the last 10 years 66
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 63
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 62
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 60
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 59
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 59
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 59
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 57
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 56
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 55
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 55
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 50
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 49
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 49
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 49
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 47
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 45
Thymoglobuline plus basiliximab a mixed cocktail to start? 45
Metabolic syndrome and cardiovascular disease in kidney transplantation 44
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 44
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 43
Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review 43
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 42
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 37
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy 36
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 36
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 31
Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney Transplantation 30
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 30
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 27
Elderly kidney transplant recipient with intermittent fever: A case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy 13
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study 12
Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970-2006 8
Totale 3.218
Categoria #
all - tutte 12.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 10 4
2019/2020309 54 15 19 3 6 11 29 4 23 9 78 58
2020/2021394 36 32 15 32 55 33 38 10 46 14 72 11
2021/2022504 36 29 11 16 19 19 16 86 20 36 101 115
2022/20231.170 149 169 68 209 57 146 73 96 157 5 24 17
2023/2024396 29 126 11 51 22 87 24 24 5 14 3 0
Totale 3.218